| ||
Raptor Pharmaceutical Obtains Tissue Fibrotic Disease Intellectual Property ... NASDAQ NOVATO, Calif., Oct. 10, 2012 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that the Company has acquired exclusive world-wide rights to intellectual property related to cysteamine and ... See all stories on this topic » | ||
Pharmaceutical Industry Shares new Policy Recommendations to Address the ... The Herald | HeraldOnline.com Today the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) released MNDs: Innovative therapies, innovative collaborations, a publication outlining policy recommendations for further research and to address the growing ... See all stories on this topic » | ||
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Teva to Present Positive ... 4-traders Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced data from the Phase III Glatiramer Acetate Low-Frequency Administration (GALA) study. The GALA study was designed to evaluate the efficacy, safety and tolerability of an investigational ... See all stories on this topic » | ||
| ||
Novasep Invests EUR 30 Million to Build World's Largest Chromatography Plant ... Lab Manager Laboratory News Novasep has pioneered continuous chromatography for pharmaceutical manufacturing for more than 20 years. Its SMB and Varicol(R) continuous chromatography technologies are currently used for commercial scale production of several chiral APIs. See all stories on this topic » | ||
Fund Managers' Favourites: Pharmaceutical Focus Morningstar In the video series, "Fund Managers' Favourites", Morningstar speaks with UK-based fund managers to learn about their top investment picks. In this video, Morningstar journalist Alanna Petroff speaks with John Bennett from Henderson Global Investors ... See all stories on this topic » | ||
Savient Pharmaceuticals May Continue To Run Higher Seeking Alpha Savient Pharmaceuticals (SVNT) enjoyed a blistering third quarter, as shareholders racked up an impressive 363% gain, making it the largest Q3 gainer in ahead of other companies such as Sarepta Therapeutics (SRPT) 313%, Hemispherx Biopharma (HEB) ... See all stories on this topic » | ||
Research and Markets: Pharmaceutical and Biotechnology Construction Sector ... The Herald | HeraldOnline.com AMA Research are pleased to announce the publication of the 1st Edition of a new report: Pharmaceutical and Biotechnology Construction Sector Report - UK 2012-2016 Analysis. The report should be of particular interest to construction companies and ... See all stories on this topic » | ||
AFPE, AAPS enter new strategic alliance to advance pharmaceutical science ... News-Medical.net The American Association of Pharmaceutical Scientists (AAPS) and the American Foundation for Pharmaceutical Education (AFPE) have entered into an exciting new strategic alliance to advance support for pharmaceutical science education. "AAPS has had ... See all stories on this topic » | ||
Avery Dennison introduces sharp tear to protect pharmaceutical brands from ... Packaging Europe Avery Dennison has launched Sharp Tear™, an important new anti-counterfeiting technology that enables existing serial numbers to be read directly through the label, providing an extra layer of product security for pharmaceutical brands. The innovative ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment